| Literature DB >> 34621950 |
Britney N Wilson1, Mary Sun2, Alyssa Gwen Ashbaugh3, Simran Ohri1, Christopher Yeh1, Dedee F Murrell4,5, Jenny E Murase6,7.
Abstract
BACKGROUND: Previous reports have revealed inadequate resident education and textbook representation of dermatological conditions in patients with skin of color (SoC). This suggests that the literature and continuing medical education are important alternative dermatology educational resources to aid in diagnosing and treating patients of color.Entities:
Keywords: Diversity; dermatology education; equity and inclusion; journal analysis; medical education; medical literature; skin of color
Year: 2021 PMID: 34621950 PMCID: PMC8484942 DOI: 10.1016/j.ijwd.2021.04.001
Source DB: PubMed Journal: Int J Womens Dermatol ISSN: 2352-6475
Journals ranked by percentage of articles on SoC from 2018 to 2020, with relevant characteristics
| SoC rank | Scopus CiteScore | Journal | Continent | SoC | Intl | Category | Total articles | SoC articles | SoC articles, % |
|---|---|---|---|---|---|---|---|---|---|
| 1 | 2 | Asia | Y | N | Clinical | 364 | 225 | 61.81 | |
| 2 | 2.5 | Asia | Y | N | Clinical | 568 | 317 | 55.81 | |
| 3 | 2 | North America | N | Y | Clinical | 195 | 106 | 54.36 | |
| 4 | 1 | Europe | Y | Y | Clinical | 140 | 69 | 49.29 | |
| 5 | 0.1 | Asia | Y | N | Clinical | 73 | 34 | 46.58 | |
| 6 | 4.2 | Asia | N | N | Clinical | 1401 | 486 | 34.69 | |
| 7 | 2.9 | Oceania | N | N | Clinical | 637 | 216 | 33.91 | |
| 8 | 1.9 | South America | Y | N | Clinical | 568 | 189 | 33.27 | |
| 9 | 1.3 | North America | N | N | Clinical | 1079 | 359 | 33.27 | |
| 10 | 1.8 | Asia | Y | N | Clinical | 438 | 143 | 32.65 | |
| 11 | 1.3 | Asia | Y | N | Clinical | 183 | 53 | 28.96 | |
| 12 | 2 | Multiple | N | Y | Clinical | 730 | 207 | 28.36 | |
| 13 | 2.4 | Europe | N | N | Scientific | 899 | 220 | 24.47 | |
| 14 | 5.6 | Europe | N | Y | Clinical | 396 | 77 | 19.44 | |
| 15 | 2.9 | Multiple | N | Y | Scientific | 197 | 38 | 19.29 | |
| 16 | 0.8 | North America | N | Y | Clinical | 709 | 132 | 18.62 | |
| 17 | 4.5 | Europe | N | Y | Clinical | 848 | 147 | 17.33 | |
| 18 | 2.9 | Multiple | N | Y | Clinical | 1318 | 209 | 15.86 | |
| 19 | 2 | North America | N | Y | Clinical | 930 | 143 | 15.38 | |
| 20 | 3 | Multiple | N | Y | Scientific | 267 | 38 | 14.23 | |
| 21 | 2.4 | North America | N | Y | Clinical | 390 | 55 | 14.10 | |
| 22 | 9.2 | North America | N | N | Clinical | 941 | 132 | 14.03 | |
| 23 | 6.1 | Multiple | N | Y | Scientific | 209 | 28 | 13.40 | |
| 24 | 1.8 | Multiple | N | Y | Clinical | 1216 | 154 | 12.66 | |
| 25 | 3.5 | Europe | N | Y | Clinical | 669 | 82 | 12.26 | |
| 26 | 2.2 | North America | N | Y | Clinical | 594 | 67 | 11.28 | |
| 27 | 2.9 | Multiple | N | Y | Scientific | 331 | 37 | 11.18 | |
| 28 | 6.6 | Europe | N | Y | Clinical | 2011 | 222 | 11.04 | |
| 29 | 3.4 | Europe | N | Y | Scientific | 203 | 22 | 10.84 | |
| 30 | 2.1 | North America | N | Y | Clinical | 309 | 30 | 9.71 | |
| 31 | 4.8 | Multiple | N | Y | Clinical | 181 | 16 | 8.84 | |
| 32 | 0.7 | North America | N | Y | Scientific | 76 | 6 | 7.89 | |
| 33 | 5.3 | Multiple | N | Y | Clinical | 323 | 23 | 7.12 | |
| 34 | 6.3 | Asia | N | N | Scientific | 466 | 33 | 7.08 | |
| 35 | 4.8 | Multiple | N | Y | Clinical | 247 | 17 | 6.88 | |
| 36 | 2.4 | Europe | N | Y | Clinical | 677 | 46 | 6.79 | |
| 37 | 3.2 | North America | N | Y | Clinical | 970 | 64 | 6.60 | |
| 38 | 4.1 | North America | N | Y | Scientific | 264 | 17 | 6.44 | |
| 39 | 3.5 | Multiple | N | Y | Clinical | 460 | 29 | 6.30 | |
| 40 | 7.6 | North America | N | N | Clinical | 221 | 13 | 5.88 | |
| 41 | 9.8 | Europe | N | N | Clinical | 2796 | 162 | 5.79 | |
| 42 | 4.6 | North America | N | N | Clinical | 252 | 14 | 5.56 | |
| 43 | 6.7 | North America | N | N | Clinical | 1797 | 88 | 4.90 | |
| 44 | 5.4 | Multiple | N | Y | Clinical | 226 | 11 | 4.87 | |
| 45 | 8.1 | Multiple | N | Y | Scientific | 1198 | 53 | 4.42 | |
| 46 | 5.4 | Multiple | N | Y | Scientific | 547 | 24 | 4.39 | |
| 47 | 1.5 | Europe | N | N | Clinical | 433 | 17 | 3.93 | |
| 48 | 5.4 | Multiple | N | Y | Clinical | 167 | 5 | 2.99 | |
| 49 | NA | Europe | N | N | Clinical | 555 | 15 | 2.70 | |
| 50 | 4.3 | Multiple | N | Y | Scientific | 267 | 7 | 2.62 | |
| 51 | 2.2 | Europe | N | N | Clinical | 388 | 9 | 2.32 | |
| 52 | 4.3 | Europe | N | Y | Scientific | 98 | 2 | 2.04 |
intl, international; N, no; SoC, skin of color; Y, yes
Fig 1Tier percentages for articles on skin of color (all journals).
Tier percentages for articles on SoC
| Journal category | SoC articles, % total articles | Tier 1A, % | Tier 1B, % | Tier 1C, % | Tier 1D, % | Tier 1E, % | Tier 2, % |
|---|---|---|---|---|---|---|---|
| Non-SoC country | 13.33 | 14.03 | 54.74 | 1.44 | 0.70 | 15.24 | 13.85 |
| SoC country | 44.13 | 5.44 | 88.64 | 0.10 | 0.00 | 0.10 | 5.73 |
| Noninternational | 19.19 | 9.53 | 69.05 | 1.33 | 0.44 | 11.64 | 8.01 |
| International | 12.57 | 15.71 | 52.63 | 0.96 | 0.69 | 12.60 | 17.41 |
| Clinical | 16.60 | 11.41 | 63.47 | 1.21 | 0.50 | 12.48 | 10.93 |
| Scientific | 2.04 | 50.00 | 0.00 | 0.00 | 0.00 | 0.00 | 50.00 |
SoC, skin of color
Fig. 2Country of origin percentages for articles on skin of color (all journals).
Geographical origin percentages for articles on SoC
| Journal category | Tier 1, % total articles | Africa, % | Asia, % | Australia, % | Caribbean, % | Central America, % | Europe, % | Middle East, % | South America, % | North America, % |
|---|---|---|---|---|---|---|---|---|---|---|
| SoC country | 11.49 | 4.01 | 56.00 | 0.33 | 0.30 | 0.42 | 5.87 | 6.73 | 5.03 | 21.31 |
| Non-SoC country | 41.60 | 2.16 | 59.94 | 0.00 | 10.81 | 0.82 | 2.06 | 5.66 | 18.13 | 0.41 |
| International | 17.85 | 1.63 | 61.46 | 0.36 | 4.42 | 0.44 | 3.55 | 5.62 | 8.77 | 13.75 |
| Noninternational | 10.38 | 6.32 | 50.53 | 0.11 | 0.22 | 0.61 | 7.04 | 7.71 | 6.88 | 20.58 |
| Clinical | 14.79 | 3.43 | 55.94 | 0.23 | 2.92 | 0.54 | 4.76 | 6.30 | 8.38 | 17.49 |
| Scientific | 8.12 | 5.15 | 65.93 | 0.49 | 0.25 | 0.25 | 7.35 | 8.33 | 4.17 | 8.09 |
SoC, skin of color
Fig. 3Patient race/ethnicity percentages for North America tier 1 articles on skin of color (all journals).
Patient race/ethnicity percentages for North American tier 1 articles on SoC
| Journal type | North America tier 1, % total articles | Asian, % | Black, % | Latino, % | Middle Eastern, % | Multiple and/or unspecified, % |
|---|---|---|---|---|---|---|
| SoC country | 2.45 | 9.55 | 34.13 | 14.33 | 2.11 | 39.89 |
| Non-SoC country | 0.17 | 0.00 | 0.00 | 75.00 | 0.00 | 25.00 |
| International | 2.45 | 9.86 | 32.75 | 13.62 | 2.61 | 41.16 |
| Noninternational | 2.14 | 9.16 | 35.04 | 15.63 | 1.62 | 38.54 |
| Clinical | 2.59 | 9.96 | 33.82 | 15.08 | 2.05 | 39.09 |
| Scientific | 0.66 | 0.00 | 36.36 | 6.06 | 3.03 | 54.55 |
SoC, skin of color
Fig. 4Scatterplot of Scopus CiteScore versus percentage of articles on skin of color (all journals).